EXPONENT, INC. vs Genpact Limited, two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EXPO and G diverge most: on debt / equity, EXPO reads 0.00 and G reads 0.46; on p/b, EXPO reads 11.42 and G reads 2.30. The rest of the comparable metrics sit closer together. What EXPO's price implies is a bet that sits within the historical range (whole-company basis). What G's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EXPO | G |
|---|---|---|
| Price | $67.30 | $35.12 |
| Market cap | $3.3B | $6.0B |
| Sector | Consulting | Consulting |
| Stage | Mature | Mature |
| Implied growth (priced in) | +19.7% | — |
| P/E | 30.3 | 10.4 |
| P/B | 11.42 | 2.30 |
| P/S | 5.21 | 1.14 |
| EV/EBITDA | 23.4 | 8.4 |
| Revenue growth | +12.7% | +6.5% |
| Gross margin | — | 36.5% |
| Operating margin | 16.3% | 14.4% |
| Net margin | 17.7% | 11.1% |
| Return on equity | 38.7% | 22.4% |
| Return on assets | 17.1% | 10.8% |
| Return on invested capital | 31.9% | 15.6% |
| FCF yield | 3.3% | 9.6% |
| Dividend yield | 1.8% | 1.9% |
| Debt / equity | 0.00 | 0.46 |
| Current ratio | 1.98 | 2.00 |
| Altman Z (solvency) | 8.32 | 2.99 |
| Piotroski F (quality) | 8 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.